by
Amanda Doreson, Project Manager | February 27, 2007
Hologic's ImageChecker was
among the many machines
that the US Army ordered.
Hologic, Inc. (NASDAQ: HOLX), a leading provider of premium imaging and interventional systems directed toward women's health, announced that the U.S. Army Medical Materiel Agency (USAMMA), Fort Detrick, Maryland, has selected Hologic for all of the mammography computer-aided detection (CAD) units the Army will purchase in 2007. The CAD systems will be installed in Army teaching Medical Centers, and large and small Army community hospitals throughout the U.S and Europe.
To date, Hologic has received orders from USAMMA for five of R2's premier ImageChecker® DMax Ultra systems, five ImageChecker DX systems, and three additional Checkmate™ Ultra display units.
"We are pleased to have been selected by the U.S. Army as their CAD provider and we look forward to partnering with these new users to provide the best breast cancer detection tools available," said Julian Marshall, product management director and principal engineer for computer aided detection at Hologic. The selection of the Hologic R2 CAD technology was made after the Army evaluated the CAD providers. R2 CAD products were selected on the basis of their expandability and flexibility and the Company's long history of innovation.

Ad Statistics
Times Displayed: 19605
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The R2 ImageChecker was the first CAD system approved by the U.S. Food and Drug Administration (FDA) for use with film-based mammography in 1998 and for digital mammography in 2001. Since 1998, R2 has received multiple supplemental approvals for technological and clinical advances and owns or has exclusive worldwide rights in more than 115 issued and pending patents. To date, more than 3,000 ImageChecker Mammography CAD systems have been sold worldwide. Hologic estimates that over ten million women will have their mammograms interpreted with the aid of R2's leading technology in 2007.